Erythromycin recalls

Erythromycin products have been recalled 2 times, most recently on 27 May 2026. The recalling company is usually Zydus Pharmaceuticals (USA). The most common reason is nitrosamine impurity.

Total recalls2since 2026

Last 12 months2reported

Class I00% of total

Ongoing2latest 27 May 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 2 0 0Jul 0 0

Severity split

Class I 0 0%Class II 2 100%Class III 0 0%

Why erythromycin is recalled

Nitrosamine Impurity2100%

Companies

Zydus Pharmaceuticals (USA)2100%

By year

20262100%

Ongoing erythromycin recalls

2 active

Reported	Class	Recall	Company	Reason	Where
27 May 2026Drug	CLASS II	Erythromycin Tablets, USP, 250 mg recalledErythromycin	Zydus Pharmaceuticals (USA)	Nitrosamine Impurity	Nationwide
27 May 2026Drug	CLASS II	Erythromycin Tablets, USP, 500 mg recalledErythromycin	Zydus Pharmaceuticals (USA)	Nitrosamine Impurity	Nationwide

All erythromycin recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
27 May 2026Drug	CLASS II	Erythromycin Tablets, USP, 250 mg recalledErythromycin	Zydus Pharmaceuticals (USA)	Nitrosamine Impurity	Nationwide
27 May 2026Drug	CLASS II	Erythromycin Tablets, USP, 500 mg recalledErythromycin	Zydus Pharmaceuticals (USA)	Nitrosamine Impurity	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.